|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-9-9
|
|
pubmed:abstractText |
A phase III randomized trial was carried out to compare two schedules of the vinorelbine (VNR)-cisplatin (CDDP) regimen in patients with locally advanced unresectable poor prognosis stage IIIB or metastatic stage IV non-small cell lung cancer. The primary endpoints were overall survival (OS) and analysis of toxicity, while secondary endpoints included response rates, time-to-progression (TTP) and quality of life (QoL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0169-5002
|
|
pubmed:author |
pubmed-author:AgostaraBiagioB,
pubmed-author:BorsellinoNicolòN,
pubmed-author:CarusoMicheleM,
pubmed-author:ColucciGiuseppeG,
pubmed-author:DuriniErnestoE,
pubmed-author:GalettaDomenicoD,
pubmed-author:GebbiaVittorioV,
pubmed-author:Gruppo Oncologico Italia Meridionale,
pubmed-author:LorussoVitoV,
pubmed-author:PezzellaGiuseppeG,
pubmed-author:ValenzaRobertoR,
pubmed-author:VerderameFrancescoF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
369-77
|
|
pubmed:meshHeading |
pubmed-meshheading:18308419-Adult,
pubmed-meshheading:18308419-Aged,
pubmed-meshheading:18308419-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18308419-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18308419-Chi-Square Distribution,
pubmed-meshheading:18308419-Cisplatin,
pubmed-meshheading:18308419-Disease Progression,
pubmed-meshheading:18308419-Female,
pubmed-meshheading:18308419-Humans,
pubmed-meshheading:18308419-Italy,
pubmed-meshheading:18308419-Logistic Models,
pubmed-meshheading:18308419-Lung Neoplasms,
pubmed-meshheading:18308419-Male,
pubmed-meshheading:18308419-Middle Aged,
pubmed-meshheading:18308419-Neoplasm Staging,
pubmed-meshheading:18308419-Prospective Studies,
pubmed-meshheading:18308419-Quality of Life,
pubmed-meshheading:18308419-Statistics, Nonparametric,
pubmed-meshheading:18308419-Treatment Outcome,
pubmed-meshheading:18308419-Vinblastine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
|
|
pubmed:affiliation |
Department of Experimental Oncology and Clinical Applications, University of Palermo, Italy. vittorio.gebbia@tin.it
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
